Class information for:
Level 1: OVERACTIVE BLADDER//TOLTERODINE//FESOTERODINE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2595 2126 29.3 71%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
59 28401 URINARY INCONTINENCE//PELVIC ORGAN PROLAPSE//NEUROUROLOGY AND URODYNAMICS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 OVERACTIVE BLADDER Author keyword 327 44% 27% 573
2 TOLTERODINE Author keyword 170 69% 7% 146
3 FESOTERODINE Author keyword 142 90% 3% 62
4 OXYBUTYNIN Author keyword 137 61% 7% 144
5 SOLIFENACIN Author keyword 114 73% 4% 87
6 DARIFENACIN Author keyword 77 79% 2% 49
7 PROPIVERINE Author keyword 69 74% 2% 51
8 ANTIMUSCARINIC Author keyword 62 56% 4% 75
9 ANTIMUSCARINICS Author keyword 55 56% 3% 66
10 TROSPIUM CHLORIDE Author keyword 52 80% 2% 32

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 OVERACTIVE BLADDER 327 44% 27% 573 Search OVERACTIVE+BLADDER Search OVERACTIVE+BLADDER
2 TOLTERODINE 170 69% 7% 146 Search TOLTERODINE Search TOLTERODINE
3 FESOTERODINE 142 90% 3% 62 Search FESOTERODINE Search FESOTERODINE
4 OXYBUTYNIN 137 61% 7% 144 Search OXYBUTYNIN Search OXYBUTYNIN
5 SOLIFENACIN 114 73% 4% 87 Search SOLIFENACIN Search SOLIFENACIN
6 DARIFENACIN 77 79% 2% 49 Search DARIFENACIN Search DARIFENACIN
7 PROPIVERINE 69 74% 2% 51 Search PROPIVERINE Search PROPIVERINE
8 ANTIMUSCARINIC 62 56% 4% 75 Search ANTIMUSCARINIC Search ANTIMUSCARINIC
9 ANTIMUSCARINICS 55 56% 3% 66 Search ANTIMUSCARINICS Search ANTIMUSCARINICS
10 TROSPIUM CHLORIDE 52 80% 2% 32 Search TROSPIUM+CHLORIDE Search TROSPIUM+CHLORIDE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TOLTERODINE 321 65% 14% 303
2 OXYBUTYNIN 168 55% 10% 211
3 TROSPIUM CHLORIDE 166 83% 4% 95
4 ANTIMUSCARINIC AGENT SOLIFENACIN 161 86% 4% 83
5 ANTIMUSCARINIC AGENT 128 87% 3% 62
6 SELECTIVE RECEPTOR ANTAGONIST 113 91% 2% 48
7 EXTENDED RELEASE TOLTERODINE 102 85% 2% 53
8 DARIFENACIN 86 90% 2% 37
9 OVERACTIVE BLADDER 82 20% 18% 373
10 MIXED URINARY INCONTINENCE 74 81% 2% 44

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LUTS-LOWER URINARY TRACT SYMPTOMS 2 10% 1% 23

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The effects of antimuscarinic treatments in overactive bladder: An update of a systematic review and meta-analysis 2008 256 33 94%
Comparative Efficacy and Safety of Medical Treatments for the Management of Overactive Bladder: A Systematic Literature Review and Mixed Treatment Comparison 2014 10 51 92%
Long-Term Adherence to Antimuscarinic Therapy in Everyday Practice: A Systematic Review 2014 8 19 79%
Efficacy and Adverse Events of Antimuscarinics for Treating Overactive Bladder: Network Meta-analyses 2012 32 112 86%
A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder 2008 84 56 98%
Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature 2011 38 153 89%
Muscarinic receptor antagonists for overactive bladder 2007 152 167 46%
The effects of antimuscarinic treatments in overactive bladder: A systematic review and meta-analysis 2005 128 39 97%
The efficacy and safety of mirabegron in treating OAB: a systematic review and meta-analysis of phase III trials 2014 6 18 61%
Anticholinergics for Overactive Bladder Therapy: Central Nervous System Effects 2012 24 59 75%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 VANDERBILT CONTINENCE 15 88% 0.3% 7
2 GE AFTSBEREICH MED MANAGEMENT MED CONTROLLING 14 100% 0.3% 7
3 UROGYNAECOL 11 15% 3.2% 67
4 EVANSTON CONTINENCE 6 28% 0.9% 19
5 BRISTOL UROL 5 12% 1.9% 41
6 MED SCI CLIN 3 57% 0.2% 4
7 NEUROUROL PROGRAM 3 45% 0.2% 5
8 BIOENGN LUTD 3 50% 0.2% 4
9 MED KLIN POLIKLIN GROSSHADERN 3 2 67% 0.1% 2
10 OUTPATIENT PAVIL 2 67% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000210202 NEUROGENIC DETRUSOR OVERACTIVITY//IDIOPATHIC DETRUSOR OVERACTIVITY//INTRADETRUSOR INJECTION
2 0.0000193389 URINARY INCONTINENCE//PELVIC FLOOR MUSCLE TRAINING//STRESS URINARY INCONTINENCE
3 0.0000161982 NOCTURIA//NOCTURNAL POLYURIA//DESMOPRESSIN
4 0.0000127396 DETRUSOR//UROPHYSIOL GRP//BLADDER
5 0.0000092606 SACRAL NEUROMODULATION//FOWLERS SYNDROME//SACRAL NERVE ROOTS
6 0.0000085486 NEUROMETER//CURRENT PERCEPTION THRESHOLD//CONTINUOUS PRESSURE
7 0.0000080009 URODYNAMICS//PRESSURE FLOW STUDY//UROFLOWMETRY
8 0.0000079419 PONTINE MICTURITION CENTER//MICTURITION//BARRINGTONS NUCLEUS
9 0.0000070089 LOWER URINARY TRACT SYMPTOMS//BENIGN PROSTATIC HYPERPLASIA//LUTS
10 0.0000058110 SPHINCTERIC DYSFUNCTION//QUALIVEEN//URINARY DISORDERS